Concord Biotech Q2 Results
- BSE: 543960
- NSE: CONCORDBIO
- ISIN: INE338H01029
- Sector: -
BSE
2,073.3
41.75 (2.06%)
41.75 (2.06%)Volume8.86 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
2,06949.70 (2.46%)
49.70 (2.46%)Volume1.66 L
Updated: Mon 25 Nov, 2024 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹310.18 Cr.(43.73%)
- Operating Profit₹123.36 Cr.(81.15%)
- Profit After Tax₹95.74 Cr.(60.66%)
- Operating Margin39.77%(-1.47%)
Note: Comparison is on YoY basis
Quarterly - Concord Biotech Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 310.18 | 194.83 | -% | 262.35 | -% |
| Selling/ General/ Admin Expenses Total | 33.66 | 28.25 | -% | 30.17 | -% |
| Depreciation/ Amortization | 13.31 | 13.04 | -% | 13.30 | -% |
| Other Operating Expenses Total | 63.52 | 54.02 | -% | 60.12 | -% |
| Total Operating Expense | 186.82 | 135.72 | -% | 156.45 | -% |
| Operating Income | 123.36 | 59.11 | -% | 105.89 | -% |
| Net Income Before Taxes | 130.34 | 71.04 | -% | 109.70 | -% |
| Net Income | 95.74 | 54.49 | -% | 81.02 | -% |
| Diluted Normalized EPS | 14.85 | 5.21 | -% | 7.74 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST